Baltimore lab to make drug

February 12, 1993

In a sign the local biotech industry might be maturing, a Baltimore company has agreed to manufacture small quantities of an anti-cancer drug for a Virginia company.

Collaborations have been rare among local biotech companies, but Cel-Sci Corp., a publicly traded biotech company in Alexandria, signed a deal with Chesapeake Biological Laboratories yesterday.

"There is starting to be enough of a critical mass here to support some collaborations," said Geert Kersten, Cel-Sci chief operating officer. ". . . I was really surprised to find someone in the area. I thought we would have to go to Boston or California."

CBL expects to expand its work force by only three or four highly trained people.

Baltimore Sun Articles
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.